Medicenna Therapeutics annual return on equity
2021
2022
2023
2024
2025
2026
Medicenna Therapeutics Return on Equity (ROE) Growth & History (MDNAF)
Medicenna Therapeutics's return on equity was −170.64% for fiscal 2026.
View full Medicenna Therapeutics company overviewMedicenna Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −170.64% | −73.42 pp |
| 2025 | 2025-03-31 | −97.22% | +49.66 pp |
| 2024 | 2024-03-31 | −146.88% | −106.94 pp |
| 2023 | 2023-03-31 | −39.94% | +36.62 pp |
| 2022 | 2022-03-31 | −76.56% | −30.02 pp |
| 2021 | 2021-03-31 | −46.54% | — |
Medicenna Therapeutics quarterly return on equity
Q4.22
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-06-30 | −244.62% | −215.41 pp |
| Q4 2026 | 2026-03-31 | −97.40% | −102.29 pp |
| Q3 2026 | 2025-12-31 | −53.04% | — |
| Q2 2026 | 2025-09-30 | −39.25% | — |
| Q1 2026 | 2025-06-30 | −29.22% | — |
| Q4 2025 | 2025-03-31 | 4.89% | — |
| Q4 2023 | 2023-03-31 | −39.94% | +36.62 pp |
| Q4 2022 | 2022-03-31 | −76.56% | — |
Medicenna Therapeutics return on equity trends
Over the last five fiscal years, Medicenna Therapeutics's return on equity decreased from −46.54% to −170.64%, a change of −124.09 percentage points. The latest reported quarter, Q1 2027, shows −244.62%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicenna Therapeutics source filings ↗